Linagliptin monotherapy in type 2 diabetes patients for...

  • Main
  • 2012 / 09
  • Linagliptin monotherapy in type 2 diabetes patients for...

Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension

Barnett, A. H., Patel, S., Harper, R., Toorawa, R., Thiemann, S., von Eynatten, M., Woerle, H.-J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12011
Date:
September, 2012
File:
PDF, 619 KB
english, 2012
Conversion to is in progress
Conversion to is failed